Current Radiopharmaceuticals
Volume 13, 3 Issues, 2020
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access
Aims & Scope
Current Radiopharmaceuticals publishes original research articles, letters, full-length/mini reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations, covering studies related to nuclear medicine, molecular imaging, radionuclide therapy, as radiology, oncology and radiotherapy and basic research. The scope of the journal also covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.
Current Radiopharmaceuticals
,Volume 13
-Number 1
Preface Open Access
Preface
Editorial Open Access
Imaging in Melanoma Management: What's New Under the Sun?
, 13(1): 3 - 5Pierpaolo Alongi*, Giuseppe Argenziano and Luigi Mansi*
DOI: 10.2174/187447101301200218111438
Imaging in Melanoma Management: What's New Under the Sun?
Review Article
Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers
, 13(1): 6 - 13Salvatore Annunziata*, Riccardo Laudicella, Federico Caobelli, Daniele A. Pizzuto and Young Aimn Working Group
DOI: 10.2174/1874471012666191015094620
Clinical Value of PET/CT in Staging Melanoma and Potential New Radiotracers
Review Article
Malignant Cutaneous Melanoma: Updates in PET Imaging
, 13(1): 14 - 23Riccardo Laudicella*, Lucia Baratto, Fabio Minutoli, Sergio Baldari and Andrei Iagaru
DOI: 10.2174/1874471012666191015095550
Malignant Cutaneous Melanoma: Updates in PET Imaging
Review Article
The Role of PET/CT in the Era of Immune Checkpoint Inhibitors: State of Art
, 13(1): 24 - 31Angelo Castello and Egesta Lopci *
DOI: 10.2174/1874471012666191015100106
The Role of PET/CT in the Era of Immune Checkpoint Inhibitors: State of Art
Review Article Open Access
Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade
, 13(1): 32 - 41Natale Quartuccio*, Massimiliano Siracusa, Marco Pappalardo, Annachiara Arnone and Gaspare Arnone
DOI: 10.2174/1874471012666191015100837
Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade
Research Article
Clinical and Prognostic Value of 18F-FDG-PET/CT in the Restaging Process of Recurrent Cutaneous Melanoma
, 13(1): 42 - 47Domenico Albano, Demetrio Familiari, Maria C. Fornito, Salvatore Scalisi, Riccardo Laudicella, Massimo Galia, Emanuele Grassedonio, Antonella Ruggeri, Gloria Ganduscio, Marco Messina, Massimiliano Spada, Massimo Midiri and Pierpaolo Alongi*
DOI: 10.2174/1874471012666191009161826
Clinical and Prognostic Value of 18F-FDG-PET/CT in the Restaging Process of Recurrent Cutaneous Melanoma
Research Article Open Access
A Preliminary Study for Quantitative Assessment with HFUS (High- Frequency Ultrasound) of Nodular Skin Melanoma Breslow Thickness in Adults Before Surgery: Interdisciplinary Team Experience
, 13(1): 48 - 55Alfonso Reginelli*, Maria P. Belfiore, Anna Russo, Fabrizio Turriziani, Elvira Moscarella, Teresa Troiani, Gabriella Brancaccio, Andrea Ronchi, Emilio Giunta, Antonello Sica, Francesco Iovino, Fortunato Ciardiello, Renato Franco, Giuseppe Argenziano, Roberto Grassi and Salvatore Cappabianca
DOI: 10.2174/1874471012666191007121626
A Preliminary Study for Quantitative Assessment with HFUS (High- Frequency Ultrasound) of Nodular Skin Melanoma Breslow Thickness in Adults Before Surgery: Interdisciplinary Team Experience
Articles Ahead of Print
Usefulness of 5 Minutes 123I-mIBG Scan in Parkinson’s Disease and Heart Failure
Viviana Frantellizzi*, Maria Ricci, Alessio Farcomeni, Mariano Pontico, Arianna Pani and Giuseppe De Vincentis
DOI: 10.2174/1874471013666200127122033
View Abstract View on PubMed
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
Angelo Castello , Sabrina Rossi and Egesta Lopci *
DOI: 10.2174/1874471013666191230144821
View Abstract View on PubMed
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
Vittorio Briganti, Vincenzo Cuccurullo*, Valentina Berti, Giuseppe Danilo Di Stasio, Flavia Linguanti, Francesco Mungai and Luigi Mansi
DOI: 10.2174/1874471013666191230143610
View Abstract View on PubMed
PET/CT and the Response to Immunotherapy in Lung Cancer
Evangelista Laura*, Matteo Sepulcri and Giulia Pasello
DOI: 10.2174/1874471013666191220105449
View Abstract View on PubMed
FDG PET/CT in the Staging of Lung Cancer
Mohsen Farsad*
DOI: 10.2174/1874471013666191223153755
View Abstract View on PubMed
Review: Alternative and New Radiopharmaceutical Agents for Lung Cancer
Silvi Telo*, Letizia Calderoni, Sara Vichi, Federico Zagni, Paolo Castellucci and Stefano Fanti
DOI: 10.2174/1874471013666191223151402
View Abstract View on PubMed
Evidence-Based Data About Prevalence and Risk of Malignancy of Thyroid Incidentalomas Detected by Different PET Radiopharmaceuticals
Giovanni Signore, Domenico Albano, Luca Giovanella, Francesco Bertagna and Giorgio Treglia*
DOI: 10.2174/1874471012666191212115732
View Abstract View on PubMed
Oxidant and Antioxidant Effects of Gentisic Acid in a 177Lu-Labelled Methionine-containing Minigastrin Analogue
Victoria Trindade* and Henia Balter
DOI: 10.2174/1874471012666190916112904
View Abstract View on PubMed
Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas
Francesco Bertagna*, Domenico Albano, Elisabetta Cerudelli, Maria Gazzilli, Raffaele Giubbini and Giorgio Treglia
DOI: 10.2174/1874471012666191017093721
View Abstract View on PubMed
Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration
Viviana Frantellizzi*, Mariano Pontico, Arianna Pani, Roberto Pani and Giuseppe De Vincentis
DOI: 10.2174/1874471012666190927115331
View Abstract View on PubMed
Abstracts Ahead of Print
123I-FP-CIT Brain SPECT Findings in Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency
Viviana Frantellizzi*, Mariano Pontico , Arianna Pani , Maria Silvia De Feo and Giuseppe De Vincentis
DOI: 10.2174/1874471013666200325101302
View Abstract
Radiotherapy planning and Molecular Imaging in Lung Cancer
Angelina Filice*, Massimiliano Casali, Patrizia Ciammella, Marco Galaverni, Federica Fioroni, Cinzia Lotti and Annibale Versari
DOI: 10.2174/1874471013666200318144154
View Abstract
The multicenter ITALIAN trial assess the performance of FDG-PET/CT related to pre-test cancer risk in patients with solitary pulmonary nodules and introduces a segmental thoracic diagnostic strategy
Marco Spadafora*, Laura Evangelista, Salvatore Fiordoro, Francesco Porcaro, Marilena Sicignano and Luigi Mansi
DOI: 10.2174/1874471013666200318142210
View Abstract
Respiratory Gating and the performance of PET/CT in pulmonary lesions.
Luca Guerra* and Crivellaro Cinzia
DOI: 10.2174/1874471013666200317144629
View Abstract
Published Contents
- Current Radiopharmaceuticals, Volume 13, 2020
- Current Radiopharmaceuticals, Volume 12, 2019
- Current Radiopharmaceuticals, Volume 11, 2018
- Current Radiopharmaceuticals, Volume 10, 2017
- Current Radiopharmaceuticals, Volume 9, 2016
- Current Radiopharmaceuticals, Volume 8, 2015
- Current Radiopharmaceuticals, Volume 7, 2014
- Current Radiopharmaceuticals, Volume 6, 2013
- Current Radiopharmaceuticals, Volume 5, 2012
- Current Radiopharmaceuticals, Volume 4, 2011
- Current Radiopharmaceuticals, Volume 3, 2010
- Current Radiopharmaceuticals, Volume 2, 2009
- Current Radiopharmaceuticals, Volume 1, 2008
Editor's Choice
New 99mTc Radiotracers for Myocardial Perfusion Imaging by SPECT
, 2019; 12(3): 171 - 186Wei Fang* and Shuang Liu*
DOI: 10.2174/1874471012666190206102214
68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers
, 2019; 12(3): 238 - 246Ferdinando Calabria*, Robert Pichler, Mario Leporace, Johannes Wolfsgruber, Pierluigi Coscarelli, Andreas Dunzinger, Orazio Schillaci, Giuseppe Lucio Cascini and Antonio Bagnato
DOI: 10.2174/1874471012666190515090755
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours
, 2019; 12(2): 98 - 106Vincenzo Cuccurullo*, Giuseppe Danilo Di Stasio and Luigi Mansi
DOI: 10.2174/1874471012666190206094555
[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations
, 2019; 12(1): 58 - 71Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*
DOI: 10.2174/1874471012666190102165053
The Production of Ac-225
, 2018; 11(3): 173 - 179Jonathan W. Engle*
DOI: 10.2174/1874471011666180418141357
NorthStar Perspectives for Actinium-225 Production at Commercial Scale
, 2018; 11(3): 180 - 191James T. Harvey*
DOI: 10.2174/1874471011666180515123848
Ga-68 Nanoparticles and Ultra-small Nanoparticle: Next Generation of PET Radiopharmaceuticals?
, 2018; 11(2): 123 - 129Mohammed Al-Qahtani, Yousif Al Malki, Hadeel Mutwali, Edward Helal-Neto and Ralph Santos-Oliveira*
DOI: 10.2174/1874471011666180418110206
Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy
, 2018; 11(1): 34 - 45Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa
DOI: 10.2174/1874471011666171229123130
Personalized & Precision Medicine in Cancer: A Theranostic Approach
, 2017; 10(3): 166 - 170Partha Choudhury* and Manoj Gupta
DOI: 10.2174/1874471010666170728094008
PET/MR Tomographs: A Review with Technical, Radiochemical and Clinical Perspectives
, 2017; 10(3): 184 - 194Giampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello*
DOI: 10.2174/1874471010666170816125051
Open Access Articles
Comparison of 99mTc Injected Activity with Prescribed Activity in Four Types of Nuclear Medicine Exams
, 2020; 13(1): 80 - 85Muhammad Isa Khan, Umme Farwa, Tahir Iqbal, Saadat Ali, Aalia Nazir and Mohsin Ijaz*
Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications
, 2020; 13(1): 63 - 79Sara Pastorino, Mattia Riondato, Licia Uccelli, Giampiero Giovacchini, Elisabetta Giovannini, Valerio Duce and Andrea Ciarmiello*
Ileal Melanoma, A Rare Cause of Small Bowel Obstruction: Report of a Case, and Short Literature Review
, 2020; 13(1): 56 - 62Emanuele Sinagra * and Carmelo Sciumè
A Preliminary Study for Quantitative Assessment with HFUS (High- Frequency Ultrasound) of Nodular Skin Melanoma Breslow Thickness in Adults Before Surgery: Interdisciplinary Team Experience
, 2020; 13(1): 48 - 55Alfonso Reginelli*, Maria P. Belfiore, Anna Russo, Fabrizio Turriziani, Elvira Moscarella, Teresa Troiani, Gabriella Brancaccio, Andrea Ronchi, Emilio Giunta, Antonello Sica, Francesco Iovino, Fortunato Ciardiello, Renato Franco, Giuseppe Argenziano, Roberto Grassi and Salvatore Cappabianca
Sentinel Node Identification in Melanoma: Current Clinical Impact, New Emerging SPECT Radiotracers and Technological Advancements. An Update of the Last Decade
, 2020; 13(1): 32 - 41Natale Quartuccio*, Massimiliano Siracusa, Marco Pappalardo, Annachiara Arnone and Gaspare Arnone
PET/CT and the Response to Immunotherapy in Lung Cancer
, 2020; 13: 1 - 8 (E-Pub Ahead of Print)Evangelista Laura*, Matteo Sepulcri and Giulia Pasello
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases)
, 2020; 13: 1 - 11 (E-Pub Ahead of Print)Vittorio Briganti, Vincenzo Cuccurullo*, Valentina Berti, Giuseppe Danilo Di Stasio, Flavia Linguanti, Francesco Mungai and Luigi Mansi
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art
, 2020; 13: 1 - 10 (E-Pub Ahead of Print)Angelo Castello , Sabrina Rossi and Egesta Lopci *
The Screening of Renoprotective Agents by 99mTc-DMSA: A Review of Preclinical Studies
, 2019; 12(3): 211 - 219Masoud Rezaei , Maryam Papie, Mohsen Cheki*, Luigi Mansi, Sean Kitson and Amirhossein Ahmadi
Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries
, 2019; 12(3): 187 - 200Efrain Araujo Perini *, Mikhail Skopchenko, Tran Thu Hong , Rahmat Harianto , Alexis Maître, Maidelys Rosa Rodríguez Rodríguez , Nathalia de Oliveira Santos , Yinglei Guo, Xiangyu Qin , Carlos A. Zeituni and Valeriia N. Starovoitova
[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations
, 2019; 12(1): 58 - 71Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*
Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level
, 2019; 12(1): 40 - 48Ingrid Kreimerman, Erick Mora-Ramirez, Laura Reyes, Manuel Bardiès, Eduardo Savio* and Henry Engler
Preparation and Biological Evaluation of 67Gallium- Labeled Iranian Hemiscorpius Lepturus Scorpion Venom
, 2019; 12: 1 - 8 (E-Pub Ahead of Print)Amir Jalali*, Mona Haddad Zahmatkesh, Amir Reza Jalilian, Amir Taheri Borujeni and Behrouz Alirezapour
Oxidant and Antioxidant Effects of Gentisic Acid in a 177Lu-Labelled Methionine-containing Minigastrin Analogue
, 2019; 12: 1 - 13 (E-Pub Ahead of Print)Victoria Trindade* and Henia Balter
Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration
, 2019; 12: 1 - 5 (E-Pub Ahead of Print)Viviana Frantellizzi*, Mariano Pontico, Arianna Pani, Roberto Pani and Giuseppe De Vincentis
Most Cited Articles
Research Article
Biochemical and histopathological evaluation of the radioprotective effects of melatonin against gamma ray-induced skin damage
, 2019; 12(1): 72-81.Dheyauldeen Shabeeb, Masoud Najafi, Ahmed Eleojo Musa, Mansoor Keshavarz, Alireza Shirazi*, Gholamreza Hassanzadeh*, Mohammed Reza Hadian and Hedayat Samandari
DOI: 10.2174/1874471012666181120163250
Review Article
State of the art and recent developments of radiopharmaceuticals for pancreatic neuroendocrine tumors imaging
, 2019; 12(2): 107-125.Angela Carollo*, Stefano Papi, Chiara M. Grana, Luigi Mansi and Marco Chinol
DOI: 10.2174/1874471012666190306104450
Research Article
Evaluating the radioprotective effect of curcumin on rat’s heart tissues
, 2019; 12(1): 23-28.Sedighe Kolivand, Peyman Amini, Hana Saffar, Saeed Rezapoor, Elahe Motevaseli*, Masoud Najafi*, Farzad Nouruzi, Dheyauldeen Shabeeb and Ahmed Eleojo Musa
DOI: 10.2174/1874471011666180831101459
Perspective
PET/MRI in neuroendocrine tumours: Blessings and curses
, 2019; 12(2): 96-97.Mapelli Paola, De Cobelli F and Maria Picchio
DOI: 10.2174/1874471012999190404151701
Research Article
Evaluation of the radioprotective effects of melatonin against ionizing radiation-induced muscle tissue injury
, 2019; 12(3): 247-255.Dheyauldeen Shabeeb, Mansoor Keshavarz , Alireza Shirazi*, Gholamreza Hassanzadeh*, Mohammed Reza Hadian, Azin Nowrouzi, Masoud Najafi* and Ahmed Eleojo Musa
DOI: 10.2174/1874471012666190219120329
Review Article
Physiopathological premises to nuclear medicine imaging of pancreatic neuroendocrine tumours
, 2019; 12(2): 98-106.Vincenzo Cuccurullo*, Giuseppe Danilo Di Stasio and Luigi Mansi
DOI: 10.2174/1874471012666190206094555
Review Article
O-(2-[<sup>18</sup>F]-Fluoroethyl)-l-tyrosine (FET) in neurooncology: A review of experimental results
, 2019; 12(3): 201-210.Carina Stegmayr, Antje Willuweit, Philipp Lohmann and Karl-Josef Langen*
DOI: 10.2174/1874471012666190111111046
Research Article
Determination of gamma camera’s calibration factors for quantitation of diagnostic radionuclides in simultaneous scattering and attenuation correction
, 2019; 12(1): 29-39.Afrouz Asgari, Mansour Ashoor, Leila Sarkhosh, Abdollah Khorshidi* and Parvaneh Shokrani
DOI: 10.2174/1874471011666180914095222
Research Article
Feasibility and evaluation of automated methods for radiolabeling of radiopharmaceutical kits with gallium-68
, 2019; 12(3): 229-237.Alban Revy, François Hallouard*, Sandrine Joyeux-Klamber, Andrea Skanjeti, Catherine Rioufol and Marc Fraysse
DOI: 10.2174/1874471012666190110170623
Review Article
Peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours
, 2019; 12(2): 126-134.Shahad Alsadik, Siraj Yusuf and Adil AL-Nahhas*
DOI: 10.2174/1874471012666190201164132
Review Article
Utility of molecular imaging with 2-deoxy-2-[fluorine-18] fluoro-d-glucose positron emission tomography (<sup>18</sup> F-FDG PET) for small cell lung cancer (SCLC): A radiation oncology perspective
, 2019; 12(1): 4-10.Omer Sager*, Ferrat Dincoglan, Selcuk Demiral, Bora Uysal, Hakan Gamsiz, Yelda Elcim, Esin Gundem, Bahar Dirican and Murat Beyzadeoglu
DOI: 10.2174/1874471012666181120162434
Editorial
Molecular imaging and theranostics in pancreatic neuroendocrine tumours: From a luminous present to an even brighter future
, 2019; 12(2): 93-95.Mapelli Paola and Luigi Mansi
DOI: 10.2174/187447101202190530074002
Review Article
Gamma emitters in pancreatic endocrine tumors imaging in the pet era: Is there a clinical space for<sup>99m</sup>Tc-peptides?
, 2019; 12(2): 156-170.Vittorio Briganti*, Vincenzo Cuccurullo, Giuseppe Danilo Di Stasio and Luigi Mansi
DOI: 10.2174/1874471012666190301122524
Review Article
Imaging of pancreatic-neuroendocrine tumours: An outline of conventional radiological techniques
, 2019; 12(2): 135-155.Muhammad Affan Zamir, Wasim Hakim*, Siraj Yusuf and Robert Thomas
DOI: 10.2174/1874471012666190214165845
Review Article
[<sup>68</sup> Ga]-dota peptide PET/CT in neuroendocrine tumors: Main clinical applications
, 2019; 12(1): 11-22.Elisabetta Giovannini, Giampiero Giovacchini, Elisa Borsò, Patrizia Lazzeri, Mattia Riondato, Rossella Leoncini, Valerio Duce and Andrea Ciarmiello*
DOI: 10.2174/1874471012666181212101244
Most Accessed Articles
68Ga/64Cu PSMA Bio-Distribution in Prostate Cancer Patients: Potential Pitfalls for Different Tracers
, 2019; 12(3): 238-246.Ferdinando Calabria*, Robert Pichler, Mario Leporace, Johannes Wolfsgruber, Pierluigi Coscarelli, Andreas Dunzinger, Orazio Schillaci, Giuseppe Lucio Cascini and Antonio Bagnato
DOI: 10.2174/1874471012666190515090755
New 99mTc Radiotracers for Myocardial Perfusion Imaging by SPECT
, 2019; 12(3): 171-186.Wei Fang* and Shuang Liu*
DOI: 10.2174/1874471012666190206102214
Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience
, 2019; 12(3): 220-228.Laura Evangelista*, Lea Cuppari, Luisa Bellu, Daniele Bertin, Mario Caccese , Pasquale Reccia, Vittorina Zagonel and Giuseppe Lombardi
DOI: 10.2174/1874471012666190115124536
Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries
, 2019; 12(3): 187-200.Efrain Araujo Perini *, Mikhail Skopchenko, Tran Thu Hong , Rahmat Harianto , Alexis Maître, Maidelys Rosa Rodríguez Rodríguez , Nathalia de Oliveira Santos , Yinglei Guo, Xiangyu Qin , Carlos A. Zeituni and Valeriia N. Starovoitova
DOI: 10.2174/1874471012666190328164253
O-(2-[18F]-Fluoroethyl)-L-Tyrosine (FET) in Neurooncology: A Review of Experimental Results
, 2019; 12(3): 201-210.Carina Stegmayr, Antje Willuweit, Philipp Lohmann and Karl-Josef Langen*
DOI: 10.2174/1874471012666190111111046
Feasibility and Evaluation of Automated Methods for Radiolabeling of Radiopharmaceutical Kits with Gallium-68
, 2019; 12(3): 229-237.Alban Revy, François Hallouard*, Sandrine Joyeux-Klamber, Andrea Skanjeti, Catherine Rioufol and Marc Fraysse
DOI: 10.2174/1874471012666190110170623
Evaluation of the Radioprotective Effects of Melatonin Against Ionizing Radiation-Induced Muscle Tissue Injury
, 2019; 12(3): 247-255.Dheyauldeen Shabeeb, Mansoor Keshavarz , Alireza Shirazi*, Gholamreza Hassanzadeh*, Mohammed Reza Hadian, Azin Nowrouzi, Masoud Najafi* and Ahmed Eleojo Musa
DOI: 10.2174/1874471012666190219120329
Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy
, 2008; 1(3): 203-208.Oyvind S. Bruland, Thora J. Jonasdottir, Darrell R. Fisher and Roy H. Larsen
DOI: 10.2174/1874471010801030203
Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma
, 2018; 11(1): 14-21.Natasha Alexander, Reza Vali, Hojjat Ahmadzadehfar, Amer Shammas and Sylvain Baruchel*
DOI: 10.2174/1874471011666171215093112
The Screening of Renoprotective Agents by 99mTc-DMSA: A Review of Preclinical Studies
, 2019; 12(3): 211-219.Masoud Rezaei , Maryam Papie, Mohsen Cheki*, Luigi Mansi, Sean Kitson and Amirhossein Ahmadi
DOI: 10.2174/1874471012666190717142316
  |
Editor-in-Chief
Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
Northern Ireland
Biography
View Full Editorial Board
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
Northern Ireland
Biography
Biography of Sean L. Kitson
Dr Kitson is an Investigator of Radiochemistry at Almac, UK. He has over 15 years of experience in the synthesis of carbon-14 labelled compounds. Dr Kitson is the Editor-in-Chief of Current Radiopharmaceuticals published by Bentham Science Publishers and the Journal of Diagnostic Imaging in Therapy. He has published over 45 research, reviews and commercial articles in the area of carbon-14 synthesis and medical imaging. His contribution to radiochemistry was acknowledged by winning the 2006 Wiley Journal of Labelled Compounds and Radiopharmaceuticals Young Scientists Award. Since, 2007 he has been a Member of the Scientific Committee for the International Isotopes Society (IIS) UK group.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Radiopharmaceuticals Journal was launched in 2008. Dr. Sean L. Kitson serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.77
Webmaster Contact: info@benthamscience.net